Halla W Reinert

Years Active: 2018-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Zammarchi, Karin Eg Havenith, Simon Chivers, Paul Hogg, Francois Bertelli, Peter Tyrer, Narinder Janghra, Halla W Reinert, John A Hartley, Patrick H van Berkel
Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody-drug Conjugate Targeting AXL-expressing Cancers. Molecular cancer therapeutics 21 (4) (2022)
Song Cho, Francesca Zammarchi, David G Williams, Carin E G Havenith, Noel R Monks, Peter Tyrer, Francois D'Hooge, Ryan Fleming, Kapil Vashisht, Nazzareno Dimasi, Francois Bertelli, Simon Corbett, Lauren Adams, Halla W Reinert, Sandamali Dissanayake, Charles E Britten, Wanda King, Karma Dacosta, Ravinder Tammali, Kevin Schifferli, Patrick Strout, Martin Korade, Mary Jane Masson Hinrichs, Simon Chivers, Eva Corey, He Liu, Sae Kim, Neil H Bander, Philip W Howard, John A Hartley, Steve Coats, David A Tice, Ronald Herbst, Patrick H van Berkel
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer. Molecular cancer therapeutics 17 (10) (2018)

Halla W Reinert.css-eqlu8i{font-size:small;padding-left:4px;}